AcelRx Pharmaceuticals EBITDA TTM
AcelRx Pharmaceuticals EBITDA TTM Chart
AcelRx Pharmaceuticals Historical EBITDA TTM DataPro Data Export
There is no data for the selected date range.
About EBITDA (TTM)
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization. EBITDA (TTM) is the sum of the last four quarters of EBITDA.
Investors often use EBITDA as a starting point for discounted cash flow analysis or to observe the performance of a business separately from its capital structure (debt vs equity financing structure).
Though EBITDA does form an excellent basis for cash flow analysis, some investors argue that it is a misleading measure since depreciation expenses are a real cost - old property, plant and equipment must eventually be replaced if a business plans to continue operations using those assets.
View EBITDA TTM for ACRX.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
ACRX EBITDA TTM Benchmarks
|Ampio Pharmaceuticals||Go Pro|
|Cyanotech Corporation||Go Pro|
|Intercept Pharmaceuticals||Go Pro|
ACRX EBITDA TTM Rankings
8217 of 16782
831 of 1410 in Healthcare
74 of 135 in Drug Manufacturers - Major
Street Insider Jun 18
Street Insider Jun 17
Fool Jun 2
PR Newswire May 29
Fool May 26